NEW YORK, April 17, 2018 - Arsenal Capital Partners (“Arsenal”), a leading private equity firm that invests in middle-market specialty industrials and healthcare business services companies, announced today an investment to purchase a majority interest in Fralock.
Founded in 1967, Fralock is a specialty materials company that designs, engineers, and manufactures high-performance components and subassemblies for world-class companies in the semiconductor equipment, life science, aerospace, and satellite industries.
Polymer Solutions Group (PSG), a leading manufacturer of specialty polymers and additives, today announced its plan to acquire the assets of Phoenix Chemical Company, Inc. The transaction is expected to close by the end of January. PSG is a portfolio company of Arsenal Capital Partners (“Arsenal”) and was established in June 2015.
Arsenal announced today that it has signed a definitive agreement to sell Accella Performance Materials, a leading North American specialty polyurethane platform, to Carlisle Companies Incorporated for $670 million.
Arsenal Capital Partners is a specialized private equity firm that invests in the U.S. middle market with a narrow and deep focus in two sectors, Specialty Industrials and Healthcare. Our philosophy is to partner with talented management teams, provide them with access to world-class operating resources and patient capital, and develop positive, open and constructive relationships that foster long-term value creation.